ODI Pharma AB ODI.ST
ODI.ST
ODI Pharma AB SPERM.ST
Spermosens AB PROGEN.ST
Prostatype Genomics AB (publ) APTA.ST
Aptahem AB (publ) FLUI.ST
Fluicell AB (publ) QLIFE.ST
Qlife Holding AB (publ) STABL.ST
Stayble Therapeutics AB (publ) GABA.ST
Gabather AB (publ) EPIS-B.ST
Episurf Medical AB (publ) CMH.ST
Chordate Medical Holding AB (publ)
ODI Pharma AB SPERM.ST
Spermosens AB PROGEN.ST
Prostatype Genomics AB (publ) APTA.ST
Aptahem AB (publ) FLUI.ST
Fluicell AB (publ) QLIFE.ST
Qlife Holding AB (publ) STABL.ST
Stayble Therapeutics AB (publ) GABA.ST
Gabather AB (publ) EPIS-B.ST
Episurf Medical AB (publ) CMH.ST
Chordate Medical Holding AB (publ)
Performance
| Periode | ODI.ST | SPERM.ST | PROGEN.ST | APTA.ST | FLUI.ST | QLIFE.ST | STABL.ST | GABA.ST | EPIS-B.ST | CMH.ST |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -40.19 % | -24.44 % | -66.38 % | -24.38 % | 15.97 % | 5.77 % | -55.02 % | -23.88 % | -58.54 % | -9.11 % |
| YTD | -48.80 % | -48.48 % | -93.50 % | -14.93 % | -37.22 % | 5.77 % | -62.16 % | -92.63 % | -64.58 % | -45.06 % |
| 1Y | -60.00 % | -69.09 % | -94.84 % | -22.47 % | -45.24 % | -9.84 % | -64.60 % | -94.69 % | -64.28 % | -87.36 % |
| 3Y | -74.40 % | -99.82 % | -99.90 % | -97.51 % | -98.68 % | -99.98 % | -94.44 % | -99.30 % | -97.30 % | -98.84 % |
| 5Y | -74.40 % | -99.91 % | -99.97 % | -99.29 % | -99.53 % | -99.99 % | -97.55 % | -99.54 % | -97.76 % | -98.86 % |
| 10Y | -86.89 % | -99.91 % | -99.97 % | -99.84 % | -99.74 % | -99.99 % | -97.15 % | -99.92 % | -99.59 % | -98.86 % |
| From the beginning | -86.89 % | -99.91 % | -99.97 % | -99.85 % | -99.74 % | -99.99 % | -97.15 % | -99.82 % | -99.28 % | -98.86 % |